Related Experiment Video
Updated: Mar 19, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
17.6K
Cyclosporine in Dermatology.
Zekayi Kutlubay1, Bigen Çakıl Erdogan2, Burhan Engin3
1Department of Dermatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey; zekayikutlubay@hotmail.com.
Skinmed
|June 21, 2016
Summary
Cyclosporine, a calcineurin inhibitor, modulates T cell immunity by blocking calcineurin. It is primarily used in dermatology for severe psoriasis and other immune-related skin conditions.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Cyclosporine is a calcineurin inhibitor with significant immunomodulatory properties.
- Its mechanism involves binding to cyclophilin, inhibiting calcineurin, and blocking early T cell immune responses.
- Initially developed to prevent organ transplant rejection.
Purpose of the Study:
- To review the dermatologic applications of cyclosporine.
- To highlight its efficacy in treating severe psoriasis.
- To discuss its use in other inflammatory skin diseases.
Main Methods:
- Literature review of cyclosporine's mechanism of action.
- Analysis of clinical studies and indications in dermatology.
- Summary of therapeutic uses and outcomes.
Main Results:
- Cyclosporine effectively suppresses T cell activation, crucial for immune-mediated diseases.
- Severe psoriasis is a primary dermatologic indication for cyclosporine.
- Established efficacy in treating atopic dermatitis, chronic idiopathic urticaria, pyoderma gangrenosum, and Behçet's disease.
Conclusions:
- Cyclosporine is a valuable therapeutic agent in dermatology for various immune-related skin conditions.
- Its immunomodulatory effects make it a key treatment for severe psoriasis and other dermatoses.
- Further research may explore expanded applications of cyclosporine in dermatologic therapy.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
602
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
602
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
649
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
649
01:23Skin Diseases and Disorders
6.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.1K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
709
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
709
01:27Acne Infection
1
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
1
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.9K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.9K